Literature DB >> 33205399

Program organization rather than choice of test determines success of cervical cancer screening: Case studies from Bangladesh and India.

Neerja Bhatla1, Ashrafun Nessa2, Kunal Oswal3, Shachi Vashist1, Paul Sebastian3, Partha Basu4.   

Abstract

The call for elimination of cervical cancer as a public health problem by the World Health Organization has led to intense focus on the burden of disease, available resources, and the possibility of introducing efficient systems for screening and treatment that allow effective cancer control in limited-resource settings. Presently, the focus is on the introduction of rapid, technologically less-demanding, affordable HPV testing. However, until such tests become widely available, the momentum that has been gained using visual inspection with acetic acid (VIA) should not be lost. Countries with limited resources and a heavy burden of cervical cancer, such as Bangladesh and India, introduced and scaled up VIA-based programs with varying degrees of programmatic organization and performance. Despite its limitations, VIA's simplicity and affordability has allowed these countries to build infrastructure, increase numbers of trained healthcare personnel, and develop a system of multilevel coordination within the health system. Such efforts will have long-term advantages provided that countries have access to an appropriate HPV test and build on their efforts to improve program organization through a strengthened health system, translating lessons learned in program implementation, logistics, and compliance with the new paradigm.
© 2020 International Federation of Gynecology and Obstetrics.

Entities:  

Keywords:  Bangladesh; Cervical cancer elimination; Cervical cancer screening; India; Quality assurance; Screening program; Visual inspection with acetic acid

Year:  2020        PMID: 33205399     DOI: 10.1002/ijgo.13486

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  6 in total

1.  Cross-sectional survey of the impact of the COVID-19 pandemic on cancer screening programs in selected low- and middle-income countries: Study from the IARC COVID-19 impact study group.

Authors:  Patricia Villain; Andre L Carvalho; Eric Lucas; Isabel Mosquera; Li Zhang; Richard Muwonge; Farida Selmouni; Catherine Sauvaget; Partha Basu
Journal:  Int J Cancer       Date:  2021-02-17       Impact factor: 7.316

2.  An international consensus on the essential and desirable criteria for an 'organized' cancer screening programme.

Authors:  Li Zhang; André L Carvalho; Isabel Mosquera; Tianmeng Wen; Eric Lucas; Catherine Sauvaget; Richard Muwonge; Marc Arbyn; Elisabete Weiderpass; Partha Basu
Journal:  BMC Med       Date:  2022-03-23       Impact factor: 8.775

3.  Cancer of the cervix uteri: 2021 update.

Authors:  Neerja Bhatla; Daisuke Aoki; Daya Nand Sharma; Rengaswamy Sankaranarayanan
Journal:  Int J Gynaecol Obstet       Date:  2021-10       Impact factor: 4.447

Review 4.  Reduced Cancer Screening Due to Lockdowns of the COVID-19 Pandemic: Reviewing Impacts and Ways to Counteract the Impacts.

Authors:  Tuan Luu
Journal:  Front Oncol       Date:  2022-07-29       Impact factor: 5.738

5.  Cervical cancer programme, Kenya, 2011-2020: lessons to guide elimination as a public health problem.

Authors:  Valerian Mwenda; Woki Mburu; Joan-Paula Bor; Mary Nyangasi; Marc Arbyn; Steven Weyers; Philippe Tummers; Marleen Temmerman
Journal:  Ecancermedicalscience       Date:  2022-08-26

Review 6.  Cervical Cancer Prevention Efforts in India.

Authors:  Neerja Bhatla; Jyoti Meena; Sarita Kumari; Dipanwita Banerjee; Prerana Singh; Jayashree Natarajan
Journal:  Indian J Gynecol Oncol       Date:  2021-06-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.